about
Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancerTrial assessing individualized options for treatment for breast cancer: the TAILORx trial.Cancer clinical trials in the era of genomic signatures: biomedical innovation, clinical utility, and regulatory-scientific hybrids.
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Show me the genes - I will tell you who/how to treat!
@ast
Show me the genes - I will tell you who/how to treat!
@en
Show me the genes - I will tell you who/how to treat!
@nl
type
label
Show me the genes - I will tell you who/how to treat!
@ast
Show me the genes - I will tell you who/how to treat!
@en
Show me the genes - I will tell you who/how to treat!
@nl
prefLabel
Show me the genes - I will tell you who/how to treat!
@ast
Show me the genes - I will tell you who/how to treat!
@en
Show me the genes - I will tell you who/how to treat!
@nl
P2860
P356
P1476
Show me the genes - I will tell you who/how to treat!
@en
P2093
Fatima Cardoso
P2860
P2888
P356
10.1186/BCR1010
P407
P577
2005-02-14T00:00:00Z
P5875
P6179
1039126734